nach oben

Erschienen in:

01.08.2009

Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia

verfasst von: Heidi Lempp, Graham Thornicroft, Morven Leese, Naomi Fearns, Helen Graves, Bernadette Khoshaba, Antonio Lasalvia, David Scott, Michele Tansella

Erschienen in: Quality of Life Research | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate whether people with long term conditions, whatever their specific nature, need to be assessed and treated for the full range of mental, physical and social problems. Main question investigated: that rheumatoid arthritis and schizophrenia will be associated with significantly greater impairment across the subscores of the SF36 scale than in reference general population samples. Specific hypothesis tested: while rheumatoid arthritis and schizophrenia will impair both physical and mental functioning, when comparing the two groups there will be a greater difference between the physical component scores than there will be between the mental/emotional component scores of the short form health survey (SF-36).

Methods

Cross sectional comparison of SF-36 subscore profiles of cohorts of: (1) people with rheumatoid arthritis attending specialist Rheumatology outpatient clinics in five London hospitals (n = 446), and (2) people with schizophrenia treated by community psychiatric teams in four sites in Europe (n = 409).

Results

Both groups had greater impairments across the whole spectrum of mental and physical problems assessed by the SF-36 than age specific normative data for the general population. The results also support our hypothesis that, comparing the people with rheumatoid arthritis and schizophrenia, we did find that there is a greater discrepancy between the physical scales than there is between the mental/emotional scales of the SF-36.

Conclusions

These findings show that whether the primary long-term condition is presenting as physical or as mental disorder, the practitioner should ensure that the full range of physical, mental and social problems is assessed and treated.

World Health Organisation. (2003). The World health report 2003—shaping the future. Geneva: WHO.

Betteridge, N. (2003). Bone and joint diseases around the world. Arthritis-the greatest health, disability, and civil rights challenge: A UK and international perspective. Journal of Rheumatology Supplement, 67, 36–37.

Woolf, A. D., & Shichikawa, K. (2003). The Tokyo declaration. Journal of Rheumatology Supplement, 67, 65.

Lempp, H., Scott, D. L., & Kingsley, G. (2006). The personal impact of rheumatoid arthritis on patients’ identity: A qualitative study. Chronic Illness, 2, 109–120.PubMed

Lempp, H., Scott, D. L., & Kingsley, G. (2006). Patients’ views on the quality of health care for rheumatoid arthritis. Rheumatology (Oxford), 45(12), 1522–1528.CrossRef

Persson, L., Berglund, K., & Sahlberg, D. (1999). Psychological factors in chronic rheumatic disease—a review. The case of rheumatoid arthritis, current research and some problems. Scandinavian Journal of Rheumatology, 28(3), 137–144.PubMedCrossRef

Disability Rights Commission. (2006). Equal rights: Closing the gap. London: Disability Rights Commission.

Amaddeo, F., Barbui, C., Perini, G., Biggeri, A., & Tansella, M. (2007). Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. Acta Psychiatrica Scandinavica, 115(4), 320–325.PubMedCrossRef

Jones, S., Howard, L., & Thornicroft, G. (2008). ‘Diagnostic overshadowing’: Worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica, 118(3), 169–171.PubMedCrossRef

10.

Scott, D. L., & Lempp, H. (2006). Outcomes associated with early rheumatoid arthritis. Expert Review of Pharmacoeconomics & Outcomes Research, 6(5), 495–508.CrossRef

11.

Simpson, C., Franks, C., Morrison, C., & Lempp, H. (2005). The patient’s journey: Rheumatoid arthritis. British Medical Journal, 331, 887–889.PubMedCrossRef

12.

Scott, D. L., Smith, C., & Kingsley, G. (2005). What are the consequences of early rheumatoid arthritis for the individual? Best Practice and Research Clinical Rheumatology, 19(1), 117–136.PubMedCrossRef

13.

Sprangers, M., deRegt, E., Andries, F., van Agt, H., Bijl, R., de Boer, J., et al. (2000). Which chronic conditions are associated with better or poorer quality of life. Journal of Clinical Epidemiology, 53(9), 895–907.PubMedCrossRef

14.

Young, A., Kaduri, G., Batley, M., Kulinskaya, E., Gough, A., Norton, S., et al. (2007). Mortality in rheumatic arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford), 46, 350–357.CrossRef

15.

Goodson, N., & Symmons, D. (2002). Rheumatoid arthritis in women: Still associated with an increased mortality. Annals of Rheumatic Disease, 61, 955–956.CrossRef

16.

Symmons, D., Jones, M., Scott, D. L., & Prior, P. (1998). Long-term mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well. Journal of Rheumatology, 25, 1072–1077.PubMed

17.

Main, C., & de C Williams, A. (2002). Musculoskeletal pain. British Medical Journal, 325, 534–537.PubMedCrossRef

18.

Dickens, C., McGowan, L., Clark-Carter, D., & Creed, F. (2002). Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosomatic Medicine, 64(1), 52–60.PubMed

19.

Fitzpatrick, R., Newman, S., Lamb, R., & Shipley, M. (1988). Social relationships and psychological well-being in rheumatoid arthritis. Social Science and Medicine, 27(4), 399–403.PubMedCrossRef

20.

Brown, G., Nicassio, P., & Wallston, K. (1989). Pain coping strategies and depression in rheumatoid arthritis. Journal of Consulting and Clinical Psychology, 57, 625–657.CrossRef

21.

Jobe, T. H., & Harrow, M. (2005). Long-term outcome of patients with schizophrenia: A review. Canadian Journal of Psychiatry, 50(14), 892–900.

22.

Saha, S., Chant, D., & McGrath, J. (2007). A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry, 64(10), 1123–1131.PubMedCrossRef

23.

Hawton, K., Sutton, L., Haw, C., & Deek, J. J. (2005). Schizophrenia and suicide: Systematic review of risk factors. British Journal of Psychiatry, 187, 9–20.PubMedCrossRef

24.

Woolf, A. D., & Pfleger, B. (2003). Burden of major musculoskeletal conditions. Bulletin World Health Organisation, 81(9), 646–656.

25.

Abdel-Nasser, A. M., Rasker, J. J., & Valkenburg, H. A. (1997). Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 27(2), 123–140.PubMedCrossRef

26.

Saha, S., Chant, D., & McGrath, J. (2008). Meta-analyses of the incidence and prevalence of schizophrenia: Conceptual and methodological issues. Internal Journal of Methods in Psychiatric Research, 17(1), 55–61.CrossRef

27.

Symmons, D., Turner, G., Webb, R., Asten, P., Barrett, E., Lunt, M., et al. (2002). The prevalence of rheumatoid arthritis in the UK: New estimates for a new century. Rheumatology (Oxford), 41(7), 793–800.CrossRef

28.

Newcomer, J. W., & Hennekens, C. H. (2007). Severe mental illness and risk of cardiovascular disease. Journal of the American Medical Association, 298(15), 1794–1796.PubMedCrossRef

29.

Katon, W., & Sullivan, M. (1990). Depression and chronic medical illness. Journal of Clinical Psychiatry, 51(3), 14.

30.

Newman, S., & Mulligan, K. (2000). The psychology of rheumatic diseases. Bailliere’s Clinical Rheumatology, 14(4), 773–786.PubMed

31.

Slade, M., Leese, M., Cahill, S., Thornicroft, G., & Kuipers, E. (2005). Patient-rated mental health needs and quality of life improvement. British Journal of Psychiatry, 187, 256–261.PubMedCrossRef

32.

Lasalvia, A., Bonetto, C., Malchiodi, F., Salvi, G., Parabiaghi, A., Tansella, M., et al. (2005). Listening to patients’ needs to improve their subjective quality of life. Psychology Health and Medicine, 35(11), 1655–1665.

33.

Thornicroft, G. (2006). Shunned: Discrimination against people with mental illness. Oxford: Oxford University Press.

34.

Scott, D. L., & Symmons, D. P. (2008). The role of specialists in managing established rheumatoid arthritis. Rheumatology (Oxford), 47, 237–238.CrossRef

35.

Graves, H., Scott D.L., Lempp, H., Weinman, J. (2009) Illness beliefs predict disability in rheumatoid arthritis. Journal of Psychosomatic Research. doi:10.1016/j.jpsychores.2009.01.006.

36.

Gray, R., Leese, M., Bindman, J., Becker, T., Burti, L., David, A., et al. (2006). Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. British Journal of Psychiatry, 189, 508–514.PubMedCrossRef

37.

Wing, J. K., Babor, T., Brugha, T., Burke, J., Cooper, J. E., Giel, R., et al. (1990). SCAN: Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry, 47(6), 589–593.PubMed

38.

Ware, J., & Sherbourn, C. (1992). The MOS, 36 item short-form health survey (SF-36). Conceptual framework and item selection. Medical Care, 30, 473–483.PubMedCrossRef

39.

Leese, M., Schene, A., Koeter, M., Meijer, K., Bindman, J., Mazzi, M., et al. (2008). SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia. Journal of Clinical Epidemiology, 61(6), 588–596.PubMedCrossRef

40.

Everitt, B., & Dunn, G. (2001). Applied multivariate data analysis (2nd ed.). London: Hodder Arnold.

41.

Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159.CrossRef

42.

Tabachnik, B. G., & Fidell, L. S. (2006). Using multivariate statistics (5th ed.). New York: Harper & Row.

43.

Ware, J. E., & Kosinski, M. (2001). SF-36 physical and mental health summary scales: A manual for users of version 1 (2nd ed.). Lincoln, RI: Quality Metric, Inc.

44.

Ware, J., Snow, K., & Kosinski, M. (1993). SF-36 Health survey manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute.

45.

LeFort, S. M. (1993). The statistical versus clinical significance debate. Image: Journal of Nursing Scholarship, 25(1), 57–62.CrossRef

46.

Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12–19.PubMedCrossRef

47.

Greenstein, G. (2003). Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. Journal of the American Dental Association, 134, 583–591.PubMed

48.

Thornicroft, G., & Rose, D. (2005). Health service research: Is there anything to learn from mental health? Journal of Health Service Research Policy, 10(1), 1–2.CrossRef

49.

Duru, G., & Fantino, B. (2008). The clinical relevance of changes in the Montgomery-Asberg depression rating scale using the minimum clinically important difference approach. Current Medical Research and Opinion, 24, 1329–1335.PubMedCrossRef

50.

Beaton, D. E., Boers, M., & Wells, G. A. (2002). Many faces of the minimal clinically important difference (MICD): A literature review and directions for future research. Current Opinion in Rheumatology, 14, 109–114.PubMedCrossRef

51.

Kosinski, M., Zhao, S. Z., Dedhiya, S., Osterhaus, J. T., & Ware, J. E., Jr. (2000). Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis and Rheumatism, 43, 1478–1487.PubMedCrossRef

52.

Kosinski, M., Kujawski, S. C., Martin, R., Wanke, L. A., Buatti, M. C., Ware, J. E., Jr, et al. (2002). Health-related quality of life in early rheumatoid arthritis: Impact of disease and treatment response. American Journal of Managed Care, 8, 231–240.PubMed

53.

Tugwell, P., Wells, G., Strand, V., Maetzel, A., Bombardier, C., Crawford, B., et al. (2000). Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a 12-month, placebo-controlled trial. Leflunomide rheumatoid arthritis investigators group. Arthritis and Rheumatism, 43, 506–514.PubMedCrossRef

54.

Veehof, M. M., ten Klooster, P. M., Taal, E., van Riel, P. L., & van de Laar, M. A. (2008). Comparison of internal and external responsiveness of the generic medical outcome study short form-36 (SF-36) with disease-specific measures in rheumatoid arthritis. The Journal of Rheumatology, 35, 610–617.PubMed

55.

Ware, J. E., & Kosinski, M. (2003). SF-36 physical and mental health summary scales. A manual for users of version 1 (2nd ed.). Lincoln Rhode Island: Quality Metric Inc.

56.

Bowling, A., Bond, M., Jenkinson, C., & Lamping, D. L. (1999). Short form 36 (SF-36) health survey questionnaire: Which normative data should be used? Comparisons between the norms provided by the Omnibus survey in Britain, the health survey for England and the Oxford healthy life survey. Journal of Public Health Medicine, 21(3), 255–270.PubMedCrossRef

57.

Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the international quality of life assessment (IQOLA) Project. Quality of Life Research, 13(2), 283–298.PubMedCrossRef

58.

Bazzichi, L., Maser, J., Piccinni, A., Rucci, P., Del, D. A., Vivarelli, L., et al. (2005). Quality of life in rheumatoid arthritis: Impact of disability and lifetime depressive spectrum symptomatology. Clinical and Experimental Rheumatology, 23(6), 783–788.PubMed

59.

Birtane, M., Uzunca, K., Tastekin, N., & Tuna, H. (2007). The evaluation of quality of life in fibromyalgia syndrome: A comparison with rheumatoid arthritis by using SF-36 health survey. Clinical Rheumatology, 26(5), 679–684.PubMedCrossRef

60.

Uhlig, T., Loge, J. H., Kristiansen, I. S., & Kvien, T. K. (2007). Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. Journal of Rheumatology, 34(6), 1241–1247.PubMed

61.

Alishiri, G. H., Bayat, N., Fathi, A. A., Tavallaii, S. A., Assari, S., & Moharamzad, Y. (2008). Logistic regression models for predicting physical and mental health-related quality of life in rheumatoid arthritis patients. Modern Rheumatology, 16(6), 601–608.CrossRef

62.

Schmitz, N., & Kruse, J. (2007). The SF-36 summary scores and their relation to mental disorders: Physical functioning may affect performance of the summary scores. Journal of Clinical Epidemiology, 60(2), 163–170.PubMedCrossRef

63.

Wells, K. B., Stewart, A., Hays, R. D., Burnam, M. A., Rogers, W., Daniels, M., et al. (1989). The functioning and well-being of depressed patients. Results from the medical outcomes study. Journal of the American Medical Association, 262(7), 914–919.PubMedCrossRef

64.

Hays, R. D., Wells, K. B., Sherbourne, C. D., Rogers, W., & Spritzer, K. (1995). Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Archives of General Psychiatry, 52(1), 11–19.PubMed

65.

Nettleton, S. (2006). The experience of chronic illness and disability. The sociology of health and illness (2nd ed., pp. 71–103). Cambridge UK: Polity Press.

66.

Paccaloni, M., Rimondini, M., Pozzan, T., & Zimmermann, C. (2008). The communication of the diagnosis of schizophrenia. Focus group findings on psychiatrists’ point of view. Epidemiologica e Psichiatra Sociale, 17(1), 65–76.

Titel: Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia
verfasst von: Heidi Lempp
Graham Thornicroft
Morven Leese
Naomi Fearns
Helen Graves
Bernadette Khoshaba
Antonio Lasalvia
David Scott
Michele Tansella
Publikationsdatum: 01.08.2009
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 6/2009
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-009-9486-y

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2009

The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW

Gender and age differences in domain-specific life satisfaction and the impact of depressive and anxiety symptoms: a general population survey from Germany

Evaluation of the psychometric properties of the SF-36 health survey for use among Turkish and Moroccan ethnic minority populations in the Netherlands

Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population

Reliability and validity of the SF-12v2 in the medical expenditure panel survey

Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample